Академический Документы
Профессиональный Документы
Культура Документы
Metformin does not usually cause low blood glucose levels (hypoglycemia).
It may occur when this drug is prescribed with other diabetes medications.
Symptoms of low blood glucose include sudden sweating, fast heartbeat,
blurred vision, dizziness or tingling hands/feet.
Overdose:
Contraindications:
Drug Interactions:
Certain diabetes drugs are used with metformin to decrease blood sugar
levels. Combination of metformin and other diabetes drugs has been
proved more effective in the treatment of diabetes than metformin alone.
However, this combination can sometimes result in severe hypoglycemia
especially early morning hypoglycemia in which the patient wakes up early
with severe sweating, flushing and tingling of hands and feet.
Diuretics are used to lower blood pressure. Taking these drugs with
metformin may interfere with the effectiveness of metformin because they
themselves can increase blood sugar levels.
Nifedipine, a calcium channel blocker used to lower blood pressure, can
increase the amount of metformin in your body. This increases the risk of
side effects from metformin.
Use of isoniazid (a drug used in TB) with metformin may make metformin
less effective.
Metformin use can result in buildup of lactic acid in the body. The entire
mechanism of this is explained under the heading mechanism of action.
Alcohol use in patients who are on metformin can cause excessive lactic acid
in the blood. Alcohol prevents lactic acid removal in the urine and thus can
cause serious side effects.
Studies have also shown that the use of alcohol in diabetes can cause severe
imbalance in blood sugar levels. So, the diabetic patients who are on
metformin are advised not to drink alcohol.
The pharmacokinetics (the way body handles the drug) of metformin is also
affected by pregnancy, which is related to the changes in renal filtration and
net tubular transport. Studies have shown that at the time of delivery, the
baby is exposed to variable concentrations of metformin from negligible to
as high as maternal concentrations.
However, baby exposure to metformin through the breast milk is low. It is
not present in the breast milk inn significant amounts.
Metformin appears to be effective and safe for the treatment of gestational
diabetes mellitus (diabetes that occur in a pregnant lady).
It has been suggested that metformin is safe for use during pregnancy.
However, as metformin can cross placenta, its use during pregnancy may
cause potential adverse effects on the mother and the fetus.
The use of metformin throughout pregnancy in women with polycystic ovary
syndrome has been shown to decrease the rates of early pregnancy loss
and preterm labor; hence protecting against fetal growth restriction.
Benefits of Metformin over other drugs:
Several drugs are available for the treatment of diabetes mellitus type 2.
There are several reasons why doctors prefer metformin over other drugs.
Some of them are discussed under this section.
First of all, it has been used clinically for several years in the management
of type 2 diabetes.
Contrary to other drugs, metformin is not known to cause any harmful or
lethal side effects.
Metformin is cost effective and patients can purchase it easily without
causing much burden on the budget.
It is a ‘euglycemic’ drug, meaning that it does not decrease blood glucose
level below normal and thus is very unlikely to cause symptoms such as
excessive sweating, flushing and tingling.
Other drugs used in diabetes such as sulfonylureas are very common in
causing these hypoglycemic symptoms. Sulfonylureas can cause severe
toxicity when accidently taken in high doses, however, metformin is devoid
of such severe toxicity.
Other drugs are not safe for use in case the patient is taking antibacterial or
antiviral agents, but metformin is safe even with these drugs.
Metformin is a drug which not only decreases blood glucose levels, but also
increases insulin sensitivity of liver and muscle cells. It is an important plus
point of using metformin instead of other drugs.
Metformin is not metabolized by liver. Thus, it is also safe for use in people
suffering from liver pathologies.
Conclusion:
Metformin is a very effective drug for the treatment of type 2 diabetes. It
has minimal side effects and can be used in all the diabetes patients. It is
also safe for use in pregnancy and lactation as it has no teratogenic effects.
However, it can cause adverse reactions if used in an alcoholic patient.
You must not start the drug on your own whether you have diabetes or not.
Always visit your doctor before starting the drug. A doctor has a better
understanding of how a drug works and interacts with patient’s body. He
knows the past medical history of the patient, is aware of the drugs he is
already taking, his allergies, any drug addiction and other personal history.
Based on this information, a doctor can decide which anti-diabetes drug will
be best for you.
References
1. National Diabetes Statistics Report Centre for disease control and prevention,
CDC https://www.cdc.gov/diabetes/data/statistics/statistics-report.html
2. Rena G, Hardie DG, Pearson ER. The mechanisms of action of
metformin. Diabetologia. 2017 Sep;60(9):1577-1585. doi: 10.1007/s00125-017-
4342-z. Epub 2017 Aug 3. PubMed PMID: 28776086; PubMed Central PMCID:
PMC5552828.
3. Wang YW, He SJ, Feng X, Cheng J, Luo YT, Tian L, Huang Q. Metformin: a
review of its potential indications. Drug Des Devel Ther. 2017 Aug 22;11:2421-
2429. doi: 10.2147/DDDT.S141675. PubMed PMID: 28860713; PubMed Central
PMCID: PMC5574599.
4. Nasri H, Rafieian-Kopaei M. Metformin: Current knowledge. J Res Med Sci. 2014
Jul;19(7):658-64. PubMed PMID: 25364368; PubMed Central PMCID:
PMC4214027.
5. Suchard JR, Grotsky TA. Fatal metformin overdose presenting with progressive
hyperglycemia. West J Emerg Med. 2008 Aug;9(3):160-4. PubMed PMID:
19561734; PubMed Central PMCID: PMC2672258.
6. Tahrani AA, Varughese GI, Scarpello JH, Hanna FW. Metformin, heart failure,
and lactic acidosis: is metformin absolutely contraindicated? BMJ. 2007 Sep
8;335(7618):508-12. doi: 10.1136/bmj.39255.669444.AE. PubMed PMID:
17823192; PubMed Central PMCID: PMC1971167.